1789 Capital, a company known for its investment strategy in the healthcare sector, has led a funding round for BlinkRx, a startup that focuses on providing affordable prescription medications.
The funding round, which also included participation from notable investors such as Fidelity Investments, 8VC, Cercano Management, and Sweetwater Private Equity, valued BlinkRx at around $2 billion.
The recent hiring of Donald Trump Jr. by 1789 Capital has also been noted.